Vault-13

BRAIDWELL LP

STAMFORD, CT · CIK 1920938 · 13F filing filed 2026-08-14

SEC-registered investment adviser since 2022 · limited partnership

$2.7bn reported value -9.8% vs Q1 2026
86positions
31.6%in top 10
24 new 21 added 36 reduced 26 sold out vs Q1 2026

Holdings, Q2 2026

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 CARIS LIFE SCIENCES INC COM CAI CAI 8,256,032 $147.1m5.44% 5.44% AddedShares held: Q3 2025 7.3m, Q4 2025 7.8m, Q1 2026 8.0m, Q2 2026 8.3m +246.6k +246,585 3.1%
2 HINGE HEALTH INC CL A HNGE HNGE 1,330,127 $110.4m4.08% 4.08% ReducedShares held: Q3 2025 910.5k, Q4 2025 1.3m, Q1 2026 1.5m, Q2 2026 1.3m -125.0k -124,996 -8.6%
3 GLAUKOS CORP COM GKOS GKOS 591,927 $82.7m3.06% 3.06% ReducedShares held: Q3 2025 780.2k, Q4 2025 922.0k, Q1 2026 763.5k, Q2 2026 591.9k -171.6k -171,578 -22.5%
4 EDGEWISE THERAPEUTICS INC COM EWTX EWTX 1,996,965 $81.1m3.00% 3.00% ReducedShares held: Q3 2025 5.2m, Q4 2025 5.2m, Q1 2026 2.3m, Q2 2026 2.0m -350.6k -350,618 -14.9%
5 SPYRE THERAPEUTICS INC COM NEW SYRE SYRE 879,467 $78.1m2.89% 2.89% ReducedShares held: Q3 2025 2.6m, Q4 2025 1.6m, Q1 2026 932.8k, Q2 2026 879.5k -53.4k -53,356 -5.7%
6 IRHYTHM TECHNOLOGIES INC COM IRTC IRTC 654,262 $77.8m2.88% 2.88% AddedShares held: Q3 2025 225.8k, Q4 2025 217.3k, Q1 2026 610.2k, Q2 2026 654.3k +44.1k +44,070 7.2%
7 NEOGENOMICS INC COM NEW NEO NEO 4,918,202 $71.8m2.65% 2.65% ReducedShares held: Q3 2025 1.8m, Q4 2025 4.6m, Q1 2026 5.6m, Q2 2026 4.9m -699.2k -699,200 -12.4%
8 KODIAK SCIENCES INC COM KOD KOD 1,787,318 $69.6m2.58% 2.58% ReducedShares held: Q3 2025 0, Q4 2025 2.1m, Q1 2026 1.8m, Q2 2026 1.8m -31.3k -31,347 -1.7%
9 XENON PHARMACEUTICALS INC COM XENE XENE 1,131,452 $68.3m2.53% 2.53% ReducedShares held: Q3 2025 3.6m, Q4 2025 1.8m, Q1 2026 1.3m, Q2 2026 1.1m -207.0k -207,000 -15.5%
10 ALPHATEC HLDGS INC NOTE 0.750% 3/1 · principal ATEC 0.75 03.15.30 · principal ATEC 0.75 03.15.30 69,121,000 $66.2m2.45% 2.45% AddedPrincipal held: Q3 2025 0, Q4 2025 0, Q1 2026 61.6m, Q2 2026 69.1m +7.5m +7,500,000 12.2%
11 MONTE ROSA THERAPEUTICS INC COM GLUE GLUE 2,451,562 $59.3m2.19% 2.19% ReducedShares held: Q3 2025 0, Q4 2025 948.3k, Q1 2026 3.2m, Q2 2026 2.5m -755.0k -755,012 -23.6%
12 DIANTHUS THERAPEUTICS INC COM DNTH DNTH 594,562 $58.0m2.14% 2.14% ReducedShares held: Q3 2025 835.1k, Q4 2025 1.3m, Q1 2026 899.4k, Q2 2026 594.6k -304.8k -304,802 -33.9%
13 NEUROCRINE BIOSCIENCES INC COM NBIX NBIX 336,171 $56.7m2.10% 2.10% ReducedShares held: Q3 2025 880.3k, Q4 2025 751.5k, Q1 2026 652.1k, Q2 2026 336.2k -315.9k -315,950 -48.5%
14 ALPHATEC HLDGS INC COM NEW ATEC ATEC 6,531,439 $56.5m2.09% 2.09% AddedShares held: Q3 2025 1.5m, Q4 2025 0, Q1 2026 2.2m, Q2 2026 6.5m +4.4m +4,358,714 200.6%
15 GENERATE BIOMEDICINES INC COM SHS GENB GENB 3,283,844 $55.4m2.05% 2.05% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 3.6m, Q2 2026 3.3m -309.2k -309,155 -8.6%
16 MARAVAI LIFESCIENCES HLDGS I COM CL A MRVI MRVI 8,702,921 $54.3m2.01% 2.01% ReducedShares held: Q3 2025 8.4m, Q4 2025 8.4m, Q1 2026 10.2m, Q2 2026 8.7m -1.5m -1,537,243 -15.0%
17 KRYSTAL BIOTECH INC COM KRYS KRYS 128,975 $47.9m1.77% 1.77% ReducedShares held: Q3 2025 520.4k, Q4 2025 202.1k, Q1 2026 182.4k, Q2 2026 129.0k -53.5k -53,450 -29.3%
18 HUMANA INC COM HUM HUM 114,500 $45.5m1.68% 1.68% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 114.5k
19 THERMO FISHER SCIENTIFIC INC COM TMO TMO 89,395 $44.8m1.66% 1.66% ReducedShares held: Q3 2025 113.9k, Q4 2025 80.7k, Q1 2026 92.9k, Q2 2026 89.4k -3.5k -3,520 -3.8%
20 KYMERA THERAPEUTICS INC COM KYMR KYMR 378,163 $43.4m1.60% 1.60% AddedShares held: Q3 2025 276.7k, Q4 2025 454.3k, Q1 2026 337.6k, Q2 2026 378.2k +40.6k +40,604 12.0%
21 RHYTHM PHARMACEUTICALS INC COM RYTM RYTM 381,128 $42.3m1.57% 1.57% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 310.6k, Q2 2026 381.1k +70.5k +70,500 22.7%
22 DAMORA THERAPEUTICS INC COM NEW COM NEW 1,620,377 $42.1m1.56% 1.56% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 894.8k, Q2 2026 1.6m +725.5k +725,531 81.1%
23 ACADIA PHARMACEUTICALS INC COM ACAD ACAD 1,646,399 $41.7m1.54% 1.54% ReducedShares held: Q3 2025 2.4m, Q4 2025 2.0m, Q1 2026 2.5m, Q2 2026 1.6m -824.8k -824,800 -33.4%
24 BRIGHTSPRING HEALTH SVCS INC COM BTSG BTSG 596,753 $41.6m1.54% 1.54% ReducedShares held: Q3 2025 0, Q4 2025 1.2m, Q1 2026 1.0m, Q2 2026 596.8k -419.8k -419,809 -41.3%
25 TRANSMEDICS GROUP INC COM TMDX TMDX 609,715 $40.5m1.50% 1.50% AddedShares held: Q3 2025 351.2k, Q4 2025 315.3k, Q1 2026 329.4k, Q2 2026 609.7k +280.3k +280,324 85.1%
26 MBX BIOSCIENCES INC COM MBX MBX 710,880 $39.2m1.45% 1.45% ReducedShares held: Q3 2025 0, Q4 2025 1.0m, Q1 2026 1.5m, Q2 2026 710.9k -781.6k -781,587 -52.4%
27 CLIMB BIO INC COM CLYM CLYM 2,797,375 $36.5m1.35% 1.35% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 1.5m, Q2 2026 2.8m +1.3m +1,267,700 82.9%
28 CAREDX INC COM CDNA CDNA 1,220,602 $34.8m1.29% 1.29% ReducedShares held: Q3 2025 2.2m, Q4 2025 1.6m, Q1 2026 2.2m, Q2 2026 1.2m -952.5k -952,544 -43.8%
29 MAZE THERAPEUTICS INC COM MAZE MAZE 1,140,040 $34.0m1.26% 1.26% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 1.1m
30 BRIGHT MINDS BIOSCIENCES INC COM NEW DRUG DRUG 483,822 $34.0m1.26% 1.26% ReducedShares held: Q3 2025 303.7k, Q4 2025 324.4k, Q1 2026 539.7k, Q2 2026 483.8k -55.9k -55,886 -10.3%
31 ACADIA HEALTHCARE COMPANY IN COM ACHC ACHC 1,141,477 $33.7m1.25% 1.25% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 645.9k, Q2 2026 1.1m +495.6k +495,577 76.7%
32 NEKTAR THERAPEUTICS COM NEW NKTR NKTR 473,617 $33.1m1.22% 1.22% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 222.7k, Q2 2026 473.6k +250.9k +250,916 112.7%
33 CORVUS PHARMACEUTICALS INC COM CRVS CRVS 2,126,298 $31.8m1.18% 1.18% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 1.8m, Q2 2026 2.1m +373.5k +373,500 21.3%
34 NURIX THERAPEUTICS INC COM NRIX NRIX 1,286,769 $31.2m1.15% 1.15% ReducedShares held: Q3 2025 0, Q4 2025 2.2m, Q1 2026 1.8m, Q2 2026 1.3m -464.0k -463,997 -26.5%
35 INSPIRE MED SYS INC COM INSP INSP 677,570 $30.2m1.12% 1.12% UnchangedShares held: Q3 2025 883.7k, Q4 2025 540.9k, Q1 2026 677.6k, Q2 2026 677.6k
36 AVALO THERAPEUTICS INC COM NEW AVTX AVTX 1,629,182 $30.1m1.11% 1.11% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 1.6m
37 ALAMAR BIOSCIENCES INC COMMON STOCK ALMR ALMR 1,083,983 $29.4m1.09% 1.09% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 1.1m
38 DANAHER CORPORATION COM DHR DHR 150,627 $28.7m1.06% 1.06% AddedShares held: Q3 2025 309.3k, Q4 2025 118.2k, Q1 2026 139.3k, Q2 2026 150.6k +11.3k +11,300 8.1%
39 INTUITIVE SURGICAL INC COM NEW ISRG ISRG 70,137 $27.9m1.03% 1.03% ReducedShares held: Q3 2025 130.2k, Q4 2025 83.4k, Q1 2026 77.3k, Q2 2026 70.1k -7.2k -7,160 -9.3%
40 ORUKA THERAPEUTICS INC COM ORKA ORKA 278,164 $26.5m0.98% 0.98% NewShares held: Q3 2025 1.4m, Q4 2025 84.8k, Q1 2026 0, Q2 2026 278.2k
41 AVALYN PHARMACEUTICALS INC COM SHS AVLN AVLN 801,395 $26.4m0.98% 0.98% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 801.4k
42 AVEANNA HEALTHCARE HLDGS INC COM AVAH AVAH 3,065,106 $26.3m0.97% 0.97% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 2.2m, Q2 2026 3.1m +861.6k +861,600 39.1%
43 BIOAGE LABS INC COM BIOA BIOA 1,033,129 $25.3m0.94% 0.94% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 1.2m, Q2 2026 1.0m -167.5k -167,458 -13.9%
44 BOSTON SCIENTIFIC CORP COM BSX BSX 587,567 $25.1m0.93% 0.93% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 346.5k, Q2 2026 587.6k +241.1k +241,100 69.6%
45 VERA THERAPEUTICS INC CL A VERA VERA 564,724 $24.2m0.90% 0.90% AddedShares held: Q3 2025 472.7k, Q4 2025 784.7k, Q1 2026 523.8k, Q2 2026 564.7k +40.9k +40,900 7.8%
46 REPLIGEN CORP COM RGEN RGEN 177,100 $24.2m0.89% 0.89% AddedShares held: Q3 2025 195.7k, Q4 2025 81.8k, Q1 2026 47.5k, Q2 2026 177.1k +129.6k +129,600 272.8%
47 ZURA BIO LTD CLASS A ORD SHS ZURA ZURA 3,980,295 $23.5m0.87% 0.87% ReducedShares held: Q3 2025 2.5m, Q4 2025 3.2m, Q1 2026 4.0m, Q2 2026 4.0m -8.7k -8,694 -0.2%
48 GUARDANT HEALTH INC COM GH GH 147,850 $22.2m0.82% 0.82% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 499.7k, Q2 2026 147.8k -351.9k -351,862 -70.4%
49 EVOLUS INC COM EOLS EOLS 3,155,209 $21.9m0.81% 0.81% AddedShares held: Q3 2025 0, Q4 2025 3.1m, Q1 2026 3.1m, Q2 2026 3.2m +50.0k +50,000 1.6%
50 NATERA INC COM NTRA NTRA 79,500 $21.6m0.80% 0.80% ReducedShares held: Q3 2025 0, Q4 2025 111.5k, Q1 2026 129.0k, Q2 2026 79.5k -49.5k -49,500 -38.4%
51 ORTHOPEDIATRICS CORP COM KIDS KIDS 1,100,370 $21.1m0.78% 0.78% UnchangedShares held: Q3 2025 1.1m, Q4 2025 1.1m, Q1 2026 1.1m, Q2 2026 1.1m
52 ELEVANCE HEALTH INC COM ELV ELV 53,960 $20.9m0.77% 0.77% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 62.1k, Q2 2026 54.0k -8.1k -8,120 -13.1%
53 TECTONIC THERAPEUTIC INC COM TECX TECX 596,900 $20.5m0.76% 0.76% ReducedShares held: Q3 2025 736.9k, Q4 2025 927.5k, Q1 2026 847.2k, Q2 2026 596.9k -250.3k -250,251 -29.5%
54 DYNE THERAPEUTICS INC COM DYN DYN 921,598 $20.5m0.76% 0.76% ReducedShares held: Q3 2025 2.7m, Q4 2025 1.5m, Q1 2026 1.7m, Q2 2026 921.6k -760.4k -760,400 -45.2%
55 NEOGENOMICS INC NOTE 0.250% 1/1 · principal NEO 0.25 01.15.28 · principal NEO 0.25 01.15.28 18,011,000 $16.9m0.62% 0.62% ReducedPrincipal held: Q3 2025 100.4m, Q4 2025 100.4m, Q1 2026 100.4m, Q2 2026 18.0m -82.4m -82,370,000 -82.1%
56 IMMUNOCORE HLDGS PLC ADS IMCR IMCR 521,327 $16.6m0.61% 0.61% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 521.3k
57 REPLIGEN CORP NOTE 1.000%12/1 · principal RGEN 1 12.15.28 · principal RGEN 1 12.15.28 16,000,000 $16.4m0.61% 0.61% ReducedPrincipal held: Q3 2025 101.0m, Q4 2025 101.0m, Q1 2026 101.0m, Q2 2026 16.0m -85.0m -85,000,000 -84.2%
58 ARGENX SE SPONSORED ADR ARGX ARGX 17,707 $16.4m0.61% 0.61% ReducedShares held: Q3 2025 76.1k, Q4 2025 31.0k, Q1 2026 84.9k, Q2 2026 17.7k -67.2k -67,232 -79.2%
59 CELLDEX THERAPEUTICS INC NEW COM NEW CLDX CLDX 436,646 $16.2m0.60% 0.60% ReducedShares held: Q3 2025 591.7k, Q4 2025 1.9m, Q1 2026 1.4m, Q2 2026 436.6k -919.4k -919,436 -67.8%
60 OVID THERAPEUTICS INC COM OVID OVID 5,919,464 $15.9m0.59% 0.59% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 5.9m
61 MANNKIND CORP COM NEW MNKD MNKD 3,458,429 $14.7m0.54% 0.54% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 3.5m
62 UNIQURE NV SHS QURE QURE 301,652 $13.9m0.51% 0.51% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 301.7k
63 X4 PHARMACEUTICALS INC COM NEW XFOR XFOR 2,922,754 $13.6m0.50% 0.50% ReducedShares held: Q3 2025 0, Q4 2025 3.4m, Q1 2026 3.3m, Q2 2026 2.9m -350.2k -350,200 -10.7%
64 ORIC PHARMACEUTICALS INC COM ORIC ORIC 1,214,540 $13.2m0.49% 0.49% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 1.1m, Q2 2026 1.2m +86.5k +86,500 7.7%
65 KINIKSA PHARMACEUTICALS INTL ORD SHS CL A KNSA KNSA 183,822 $11.8m0.43% 0.43% ReducedShares held: Q3 2025 643.2k, Q4 2025 313.8k, Q1 2026 272.5k, Q2 2026 183.8k -88.7k -88,700 -32.5%
66 OCULIS HOLDING AG ORDINARY SHARES OCS OCS 834,183 $11.6m0.43% 0.43% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 834.2k
67 ACLARIS THERAPEUTICS INC COM ACRS ACRS 2,142,348 $11.3m0.42% 0.42% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 1.7m, Q2 2026 2.1m +443.2k +443,232 26.1%
68 SEAPORT THERAPEUTICS INC COMMON STOCK SPTX SPTX 500,000 $10.9m0.40% 0.40% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 500.0k
69 VOR BIOPHARMA INC COM NEW VOR VOR 573,104 $10.6m0.39% 0.39% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 466.8k, Q2 2026 573.1k +106.3k +106,330 22.8%
70 SURROZEN INC COM NEW SRZN SRZN 390,753 $10.1m0.38% 0.38% ReducedShares held: Q3 2025 140.0k, Q4 2025 470.0k, Q1 2026 396.1k, Q2 2026 390.8k -5.3k -5,347 -1.4%
71 IMMUNIC INC COM NEW IMUX IMUX 645,010 $9.9m0.37% 0.37% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 645.0k
72 HELIX ACQUISITION CORP III USD CL A ORD SHS HLXC HLXC 900,000 $9.5m0.35% 0.35% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 900.0k, Q2 2026 900.0k
73 IONIS PHARMACEUTICALS INC COM IONS IONS 116,762 $9.3m0.34% 0.34% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 130.9k, Q2 2026 116.8k -14.1k -14,100 -10.8%
74 QUEST DIAGNOSTICS INC COM DGX DGX 43,200 $9.2m0.34% 0.34% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 43.2k
75 ADLAI NORTYE LTD SPONSORED ADS ANL ANL 795,214 $9.1m0.34% 0.34% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 795.2k
76 TENAX THERAPEUTICS INC COM NEW TENX TENX 584,412 $8.5m0.31% 0.31% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 584.4k
77 KARDIGAN INC COM KARD KARD 300,000 $7.2m0.26% 0.26% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 300.0k
78 AMANAT ACQUISITION CORP CL A ORD AMAN AMAN 700,000 $7.1m0.26% 0.26% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 700.0k
79 HEMAB THERAPEUTICS HLDGS INC COM SHS COAG COAG 160,000 $5.9m0.22% 0.22% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 160.0k
80 GH RESEARCH PLC ORDINARY SHARES GHRS GHRS 207,240 $5.6m0.21% 0.21% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 207.2k
81 WATERS CORP COM WAT WAT 14,040 $5.3m0.19% 0.19% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 14.0k
82 RESEARCH ALLIANCE CORP III ORD SHS CL A RACC RACC 400,000 $4.3m0.16% 0.16% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 400.0k
83 JATT II ACQUISITION CORP ORD SHS JATT JATT 250,000 $2.8m0.11% 0.11% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 250.0k
84 PULMONX CORP COM LUNG LUNG 752,541 $978.3k0.04% 0.04% UnchangedShares held: Q3 2025 752.5k, Q4 2025 752.5k, Q1 2026 752.5k, Q2 2026 752.5k
85 VYNE THERAPEUTICS INC COM COM 916,077 $596.1k0.02% 0.02% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 916.1k, Q2 2026 916.1k
86 CYCLERION THERAPEUTICS INC COM COM 156,890 $531.9k0.02% 0.02% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 156.9k

Sold out since Q1 2026

SecurityTickerShares held beforeValue then
GUARDANT HEALTH INC GH 1.25 02.15.31 GH 1.25 02.15.31 60,954,000 $102.6m61.0m shares
CENTESSA PHARMACEUTICALS PLC 1,986,768 $78.9m2.0m shares
NUVALENT INC 700,429 $71.8m700.4k shares
CG ONCOLOGY INC CGON CGON 984,783 $66.7m984.8k shares
APOGEE THERAPEUTICS INC 478,667 $40.3m478.7k shares
PENUMBRA INC PEN PEN 105,352 $34.6m105.4k shares
SOLENO THERAPEUTICS INC SLNO SLNO 959,259 $32.1m959.3k shares
ILLUMINA INC ILMN ILMN 229,215 $28.3m229.2k shares
BIOMARIN PHARMACEUTICAL INC BMRN BMRN 497,020 $28.1m497.0k shares
ESTABLISHMENT LABS HLDGS INC ESTA ESTA 463,600 $26.3m463.6k shares
FULCRUM THERAPEUTICS INC FULC FULC 3,134,922 $24.0m3.1m shares
CVS HEALTH CORP CVS CVS 290,700 $20.9m290.7k shares
TARSUS PHARMACEUTICALS INC TARS TARS 265,715 $18.6m265.7k shares
ENGENE HOLDINGS INC 2,456,870 $16.7m2.5m shares
ZENAS BIOPHARMA INC ZBIO 2.5 04.01.32 ZBIO 2.5 04.01.32 13,000,000 $13.5m13.0m shares
TG THERAPEUTICS INC TGTX TGTX 358,800 $11.9m358.8k shares
CENTENE CORP DEL CNC CNC 330,000 $10.8m330.0k shares
COMPASS THERAPEUTICS INC CMPX CMPX 1,965,106 $10.4m2.0m shares
REVOLUTION MEDICINES INC RVMD RVMD 84,900 $8.3m84.9k shares
GRAIL INC GRAL GRAL 142,755 $7.4m142.8k shares
DENALI THERAPEUTICS INC DNLI DNLI 296,324 $5.7m296.3k shares
HARROW INC HROW HROW 156,419 $5.5m156.4k shares
REVVITY INC RVTY RVTY 48,400 $4.2m48.4k shares
CELCUITY INC CELC CELC 29,198 $3.3m29.2k shares
PRAXIS PRECISION MEDICINES I PRAX PRAX 9,976 $3.2m10.0k shares

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
AMANAT ACQUISITION CORP AMAN · 13G · filed 2026-08-14 AMAN 9.3%≈ $7.1m new 13G 2026-08-14